Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nexgel (NXGL) Change in Cash (2019 - 2025)

Historic Change in Cash for Nexgel (NXGL) over the last 7 years, with Q3 2025 value amounting to $1.1 million.

  • Nexgel's Change in Cash rose 1143000.0% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $799000.0, marking a year-over-year increase of 13620.3%. This contributed to the annual value of -$893000.0 for FY2024, which is 15584.74% down from last year.
  • As of Q3 2025, Nexgel's Change in Cash stood at $1.1 million, which was up 1143000.0% from -$467000.0 recorded in Q2 2025.
  • In the past 5 years, Nexgel's Change in Cash ranged from a high of $12.1 million in Q4 2021 and a low of -$6.1 million during Q2 2022
  • For the 5-year period, Nexgel's Change in Cash averaged around $119555.6, with its median value being -$369500.0 (2023).
  • In the last 5 years, Nexgel's Change in Cash crashed by 539230.77% in 2021 and then soared by 1143000.0% in 2025.
  • Quarter analysis of 5 years shows Nexgel's Change in Cash stood at $12.1 million in 2021, then plummeted by 124.75% to -$3.0 million in 2022, then surged by 81.09% to -$566000.0 in 2023, then soared by 232.16% to $748000.0 in 2024, then skyrocketed by 51.47% to $1.1 million in 2025.
  • Its Change in Cash was $1.1 million in Q3 2025, compared to -$467000.0 in Q2 2025 and -$615000.0 in Q1 2025.